OQROSign up free
Insider trade

Onemednet (ONMD): Director bought ~$750K

Thomas Kosasa, Director at Onemednet, bought ~$750K of Onemednet shares.

~$750K
Approx. value · 130K sh @ $5.78
1.98M
Holds after · shares reported
Traded
Oct 7, 2026
Filed
Oct 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 10, 2026Insider · 8 days before an 8-KDirector purchased ~$90K of ONMD shares in the open market
  2. Sep 14, 2026InsiderCFO sold ~$17K of ONMD shares in the open market
  3. Sep 15, 2026InsiderCFO sold ~$19K of ONMD shares in the open market
  4. Sep 18, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On September 18, 2026, OneMedNet Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) as a virtual meeting online via live audio webcast, at which the Company’s stockholders approved an amendment and restatement of the OneMedNet Corporation Amended and Restated 2022 Equity Incentive Plan (as amended and restated, the “2022 Plan”).”
  5. Sep 21, 2026InsiderCFO sold ~$20K of ONMD shares in the open market
  6. Sep 22, 2026InsiderCEO sold ~$37K of ONMD shares in the open market
  7. Sep 24, 2026InsiderCEO sold ~$11K of ONMD shares in the open market
  8. Sep 26, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year
  9. Oct 7, 2026 · this disclosureInsiderDirector purchased ~$750K of ONMD shares in the open market

What came next

  1. Oct 9, 2026InsiderDirector purchased ~$250K of ONMD shares in the open market
  2. Nov 6, 2026Company filing · Form 8-K · ResultsReported its results
  3. Nov 9, 2026Company filing · Form 8-K · ResultsReported its results
  4. Nov 13, 20265% stakeTD SECURITIES (USA) LLC reported a passive stake (13G) of 4.6%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Onemednet

For Onemednet, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONMD page.

Other recent filings by Thomas Kosasa, Director

The full history of Thomas Kosasa, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Onemednet

Everything OQRO holds on this company is on its ONMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data